Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/NV/Enterprise
Updated August 2026 from ClinicalTrials.gov

Paid Clinical Trials in Enterprise, NV

Studies commonly pay $75 to $4,500 per completed study

454 clinical trials are currently recruiting participants within 30 miles of Enterprise. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

454studies recruiting
9+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Enterprise right now

Top 25 of 454 recruiting studies, sorted by proximity — each links to its official registry page

Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer

Previously Treated Non-Small Cell Lung Cancer Phase 2, Phase 3 Interventional 10,000 participants sought
Las Vegas Urology - Pecos — Las Vegas, Nevada (12.5 mi) · Sponsor: SWOG Cancer Research Network
See eligibility & contact on ClinicalTrials.gov (NCT03851445)

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

B Acute Lymphoblastic Leukemia Phase 2 Interventional 222 participants sought
Alliance for Childhood Diseases/Cure 4 the Kids Foundation — Las Vegas, Nevada (12.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06124157)

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

Hyperphosphatemia, Chronic Kidney Disease Requiring Chronic Dialysis Phase 2 Interventional 168 participants sought
DaVita Clinical Research — Las Vegas, Nevada (12.5 mi) · Sponsor: R1 Therapeutics
See eligibility & contact on ClinicalTrials.gov (NCT06712654)

A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations

Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma Phase 2 Interventional 40 participants sought
Ohio State University-Telemedicine — Las Vegas, Nevada (12.5 mi) · Sponsor: Sameek Roychowdhury
See eligibility & contact on ClinicalTrials.gov (NCT06906562)

A Study to Investigate Canvuparatide Compared With Placebo in Adult Patients With Hypoparathyroidism

Hypoparathyroidism Phase 3 Interventional 160 participants sought
MBX Biosciences Investigational Site — Las Vegas, Nevada (12.5 mi) · Sponsor: MBX Biosciences
See eligibility & contact on ClinicalTrials.gov (NCT07699471)

Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer

Stage I Uterine Corpus Carcinoma or Carcinosarcoma AJCC v8 Phase 3 Interventional 428 participants sought
Women's Cancer Center of Nevada — Las Vegas, Nevada (12.5 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05646316)

Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations

Non-Small Cell Lung Cancer Phase 3 Interventional 675 participants sought
Research Site — Las Vegas, Nevada (12.5 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06357533)

DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer

Endometrial Cancer Phase 3 Interventional 600 participants sought
Research Site — Las Vegas, Nevada (12.5 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06989112)

A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract

Carcinoma, Transitional Cell, Urinary Bladder Neoplasms Phase 3 Interventional 450 participants sought
Comprehensive Cancer Centers of Nevada — Las Vegas, Nevada (12.5 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07218380)

Study of AZD2389 Safety, Tolerability, and Pharmacodynamics in Adults With Steatotic Liver Disease and Advanced Fibrosis

Liver Fibrosis, Hepatic Cirrhosis Phase 2 Interventional 104 participants sought
Research Site — Las Vegas, Nevada (12.5 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT07610837)

Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma

Smoldering Plasma Cell Myeloma Phase 3 Interventional 288 participants sought
Las Vegas Urology - Pecos — Las Vegas, Nevada (12.5 mi) · Sponsor: ECOG-ACRIN Cancer Research Group
See eligibility & contact on ClinicalTrials.gov (NCT03937635)

Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)

Malignant Female Reproductive System Neoplasm, Malignant Solid Neoplasm Phase 2 Interventional 70 participants sought
OptumCare Cancer Care at Charleston — Las Vegas, Nevada (12.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT06126276)

Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)

Triple-Negative Breast Cancer Phase 3 Interventional 1,530 participants sought
Optum Care Cancer Center ( Site 9535) — Las Vegas, Nevada (12.5 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06393374)

A Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine

Menstrual Migraine Phase 3 Interventional 723 participants sought
Excel Clinical Research, LLC — Las Vegas, Nevada (12.5 mi) · Sponsor: Pfizer
See eligibility & contact on ClinicalTrials.gov (NCT06641466)

Multicenter Study of Lumateperone for the Treatment of Irritability Associated With Autism Spectrum Disorder in Pediatric Patients

Irritability Associated With Autism Spectrum Disorder Phase 3 Interventional 160 participants sought
Vector Clinical Trials — Las Vegas, Nevada (12.5 mi) · Sponsor: Intra-Cellular Therapies, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06690398)

A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension

Uncontrolled Hypertension Phase 2 Interventional 280 participants sought
Retension Clinical Site — Las Vegas, Nevada (12.5 mi) · Sponsor: Retension Pharmaceuticals. Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07142356)

LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis

Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate Phase 2 Interventional 1,431 participants sought
Digestive Disease Specialists - Las Vegas - Crimson Canyon Drive — Las Vegas, Nevada (12.5 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT07415044)

Treatment of Acute Ischemic Stroke (ReMEDy2 Trial)

Acute Stroke, Ischemic Stroke Phase 2, Phase 3 Interventional 728 participants sought
University Medical Center of Southern Nevada — Las Vegas, Nevada (12.5 mi) · Sponsor: DiaMedica Therapeutics Inc
See eligibility & contact on ClinicalTrials.gov (NCT05065216)

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm Phase 2 Interventional 2,000 participants sought
OptumCare Cancer Care at Charleston — Las Vegas, Nevada (12.5 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05564390)

Lp(a) Lowering Study of Pelacarsen (TQJ230) With Background Inclisiran in Participants With Elevated Lp(a) and Established ASCVD

Atherosclerotic Cardiovascular Disease (ASCVD) Phase 3 Interventional 340 participants sought
AB Clinical Trials — Las Vegas, Nevada (12.5 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06813911)

A Clinical Trial to Evaluate the Effects of an Omega-3-containing Supplement on DHA and EPA Levels in the Blood

Omega-3 Deficiency, DHA and EPA Blood Levels N/A Interventional 49 participants sought
Citruslabs — Las Vegas, Nevada (12.5 mi) · Sponsor: Revive Active
See eligibility & contact on ClinicalTrials.gov (NCT07753174)

REFINE Study: A Study In a Novel Interspinous Fusion Device In Subjects With Low Back Pain

Lumbar Spinal Stenosis N/A Interventional 100 participants sought
Comprehensive & Interventional Pain Management — Henderson, Nevada (13.9 mi) · Sponsor: Pacific Research Institute
See eligibility & contact on ClinicalTrials.gov (NCT05504499)
Actively enrolling

Studies you may be able to join near Enterprise

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

Research study for alcohol-related liver damage

Enrolling US adults aged 18 to 70 with alcohol-induced liver damage and a history of heavy drinking. Not open to people with a recent stroke, heart attack, dialysis, or who take blood thinners.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility

Research study for bladder problems after spinal cord injury

This study is enrolling US adults aged 18 to 75 living with chronic involuntary bladder leakage caused by a spinal cord injury, for research including investigational gene therapy approaches. The study team confirms eligibility and any compensation before enrollment.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Enterprise

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Las Vegas Medical Research Center

★ 5.0
8530 W Sunset Rd #300, Las Vegas, NV 89113
(702) 750-0222

Henderson Clinical Trials

★ 4.3
2970 W Horizon Ridge Pkwy, Henderson, NV 89052
(725) 218-3236
"When I first arrived to facility, I was greeted, and guided on what to do as it was my first time, the staff was very friendly and pleasant. The faci…"
— Kathie Galati, 5★

M3 Wake Research Las Vegas

★ 4.5
2020 Wellness Wy, Las Vegas, NV 89106
(702) 893-8968
"Everyone who works at this facility are all very kind, respectful and most important answer all your calls, emails and your questions when you go to…"
— b penelope 09, 5★

Palm Research Center Inc

9280 W Sunset Rd Ste 306, Las Vegas, NV 89148
(702) 736-5161

PPD - Las Vegas Research Unit

★ 3.0
8285 W Arby Ave #331, Las Vegas, NV 89113
(877) 773-3707
"I was fortunate enough to participate in a study that began with a 3 night stay. Everyone was very professional and pleasant to work with. The food w…"
— RJCHOICE, 5★

Desert Clinical Research

2780 W Horizon Ridge Pkwy #40, Henderson, NV 89052
(702) 957-1811

Synexus - Henderson

★ 2.6
8285 W Arby Ave Suite 380, 3rd Floor, Las Vegas, NV 89113
(702) 444-4770
"Professional medical facility. The staff is friendly and helpful. I was very satisfied with my experience."
— Keith Schoose, 5★

Las Vegas Clinical Trials

★ 4.6
1815 E Lake Mead Blvd #307, North Las Vegas, NV 89030
(702) 637-3223
"Friendly and professional staff!"
— A Fabian, 5★

Alliance Clinical Las Vegas

★ 2.7
3059 S Maryland Pkwy #202, Las Vegas, NV 89109
(702) 680-1500
"These ladies and gentlemen are all very professional & nice .I got paid as promised and I would recommend Excel for someone wanting to participate in…"
— Kelly Mazza, 5★

Clinical trials in Enterprise: what's recruiting

The Enterprise area currently has 454 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Enterprise, the most active research areas are:

  • Cancer & Oncology10 studies
  • Heart & Vascular4 studies
  • Liver & Kidney2 studies
  • Immune & Skin1 studies

Every listing shows the study phase, the recruiting site and its distance from Enterprise, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Enterprise

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Enterprise participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Enterprise pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Enterprise?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Enterprise safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Enterprise, NV?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
How often do new paid studies open in Enterprise?
Constantly — trials open and close enrollment every week. This page is refreshed weekly from the NIH registry. Join the email alert to be notified when a new study opens within 30 miles of Enterprise.

Paid clinical trials near Enterprise

Other metros within reach

Spring Valley, NV454 Paradise, NV454 Henderson, NV454 Las Vegas, NV454 Sunrise Manor, NV454 North Las Vegas, NV454 St. George, UT26 Indio, CA70

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Enterprise Bladder Issues Due To Spinal Cord Injury in Enterprise All conditions

More of NV

Las Vegas454 Henderson454 North Las Vegas454 Spring Valley454 Sunrise Manor454 Paradise454 Reno190

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts